GS 389 is a novel tetrahydroisoquinoline analogue. GS-389 significantly increased cGMP levels in the rat aorta and inhibited cGMP phosphodiesterase from the rabbit brain. It has vasorelaxant properties. References: Chang KC, Chong WS, Lee IJ. Different pharmacological characteristics of structurally similar benzylisoquinoline analogs, papaverine, higenamine, and GS 389, on isolated rat aorta and heart. Can J Physiol Pharmacol. 1994 Apr;72(4):327-34. PubMed PMID: 7922863.

纯度：≥98%

CAS：41498-37-7